Insomnia brain study tests drug to calm nighttime hyperarousal
NCT ID NCT07392177
First seen Feb 06, 2026 · Last updated May 23, 2026 · Updated 13 times
Summary
This pilot study aims to understand the brain mechanisms behind insomnia by testing a drug that may reduce overactivity in a specific brain region during sleep. Fifteen adults with insomnia will receive the drug and a placebo in random order. The main goal is to measure brain wave patterns, not to treat insomnia directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Woolcock Institute of Medical Research
Macquarie Park, New South Wales, 2113, Australia
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.